Maternal-Fetal Exposome and Early-Life Microbiota-Pattern Recognition Receptors Signaling in Inflammatory Bowel Disease Susceptibility: A Mechanistic Review.
- 1Department of Clinical Immunology, Faculty of Medicine, Wroclaw Medical University, Parkowa 34, 51-616 Wroclaw, Poland.
Abstract
Inflammatory bowel disease (IBD) develops through interactions among genetic susceptibility, intestinal microbiota, environmental exposures, and dysregulated mucosal immunity. Increasing evidence suggests that these interactions may begin before diagnosis-and possibly before birth-when maternal signals, microbial assembly, epithelial maturation, and immune education intersect. This narrative review synthesizes findings from human observational and cohort studies, experimental animal and cellular models, and mechanistic literature to examine how prenatal and early-life exposures may influence later IBD susceptibility. Human cohort studies associate later IBD with several early-life exposures, particularly repeated antibiotic use, whereas evidence for dietary, delivery, and household factors remains heterogeneous and vulnerable to confounding. Studies of pregnancies affected by IBD identify altered maternal and infant microbial and immune features but do not establish causality. Experimental models provide stronger mechanistic evidence that maternal microbial signals influence offspring immune development, neonatal epithelial cells acquire context-dependent tolerance, and microbial metabolites regulate regulatory T cells, type 17 immunity, barrier function, and chromatin-modifying enzymes. Histamine-receptor signaling further illustrates receptor-specific modulation of bacterial TLR (Toll-like receptors) responses in established IBD, although its role in early-life programming remains unproven. We propose a testable "developmental inflammatory set-point" model in which cell type, tissue compartment, timing, signal intensity, and host genotype determine whether microbial sensing promotes tolerance or persistent inflammatory readiness. This model is biologically plausible but remains unvalidated as a predictor of human IBD.
Related
- Pattern recognition receptors and divergent disease severity in zoonotic viral infections
- A sunflower FLS2 guides reconstruction of recognition of a Xanthomonas flg22 escape variant across divergent FLS2 receptors
- Convergent recognition of tobamovirus movement proteins by phylogenetically distinct NLR immune receptors
- Unveiling structural determinants of peptide recognition by public and private SARS-CoV-2-specific T-cell receptors.
- Diverse bacterial pattern recognition receptors sense the core phage proteome
BibTeX
@article{jurkiewicz2026maternalfetal,
title = {{Maternal-Fetal Exposome and Early-Life Microbiota-Pattern Recognition Receptors Signaling in Inflammatory Bowel Disease Susceptibility: A Mechanistic Review.}},
author = {Krzysztof Jurkiewicz and Sylwia Smolinska-Wilczynska},
journal = {International journal of molecular sciences},
year = {2026},
month = sep,
doi = {10.3390/ijms27198458},
url = {https://europepmc.org/article/MED/42883711},
note = {CC BY},
}
RIS
TY - JOUR
TI - Maternal-Fetal Exposome and Early-Life Microbiota-Pattern Recognition Receptors Signaling in Inflammatory Bowel Disease Susceptibility: A Mechanistic Review.
AU - Krzysztof Jurkiewicz
AU - Sylwia Smolinska-Wilczynska
PY - 2026
DA - 2026/09/23
JO - International journal of molecular sciences
DO - 10.3390/ijms27198458
UR - https://europepmc.org/article/MED/42883711
AB - Inflammatory bowel disease (IBD) develops through interactions among genetic susceptibility, intestinal microbiota, environmental exposures, and dysregulated mucosal immunity. Increasing evidence suggests that these interactions may begin before diagnosis-and possibly before birth-when maternal signals, microbial assembly, epithelial maturation, and immune education intersect. This narrative review synthesizes findings from human observational and cohort studies, experimental animal and cellular models, and mechanistic literature to examine how prenatal and early-life exposures may influence later IBD susceptibility. Human cohort studies associate later IBD with several early-life exposures, particularly repeated antibiotic use, whereas evidence for dietary, delivery, and household factors remains heterogeneous and vulnerable to confounding. Studies of pregnancies affected by IBD identify altered maternal and infant microbial and immune features but do not establish causality. Experimental models provide stronger mechanistic evidence that maternal microbial signals influence offspring immune development, neonatal epithelial cells acquire context-dependent tolerance, and microbial metabolites regulate regulatory T cells, type 17 immunity, barrier function, and chromatin-modifying enzymes. Histamine-receptor signaling further illustrates receptor-specific modulation of bacterial TLR (Toll-like receptors) responses in established IBD, although its role in early-life programming remains unproven. We propose a testable "developmental inflammatory set-point" model in which cell type, tissue compartment, timing, signal intensity, and host genotype determine whether microbial sensing promotes tolerance or persistent inflammatory readiness. This model is biologically plausible but remains unvalidated as a predictor of human IBD.
SN - 1422-0067
ER -